Funding values genetics company 23andMe at $1.1 billion

Oct 14 (Reuters) - Genetics company 23andMe on Wednesday said it raised $115 million in new venture capital funding, which implies a total value for the company of $1.1 billion, according to a source familiar with the Silicon Valley-based company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.